Integrating evidence-based medicine into the perioperative care of cardiac surgery patients

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 25, Issue 2, 2011, Pages 335-346

  Hatton, Kevin W ^a   Flynn, Jeremy D ^a   Lallos, Christine ^b   Fahy, Brenda G ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

cardiac surgery; evidence based medicine; perioperative care

Indexed keywords

ACETYLSALICYLIC ACID; AMINOCAPROIC ACID; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIFIBRINOLYTIC AGENT; ANTITHROMBIN; ANTIVITAMIN K; APROTININ; ATYPICAL ANTIPSYCHOTIC AGENT; CEFAZOLIN; CHLORHEXIDINE GLUCONATE; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; FONDAPARINUX; FRESH FROZEN PLASMA; HALOPERIDOL; HEPARIN; HIRULOG; INSULIN; LOW MOLECULAR WEIGHT HEPARIN; NEUROLEPTIC AGENT; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THIENOPYRIDINE DERIVATIVE; THROMBIN INHIBITOR; TRANEXAMIC ACID; UNINDEXED DRUG; VANCOMYCIN; VITAMIN K GROUP; WARFARIN;

ADVERSE OUTCOME; ANTIBIOTIC PROPHYLAXIS; ANTICOAGULANT THERAPY; ARTIFICIAL VENTILATION; BLEEDING; BLOOD GLUCOSE MONITORING; BLOOD TRANSFUSION; CATHETER INFECTION; COGNITIVE DEFECT; CONTINUOUS INFUSION; COST OF ILLNESS; DEEP STERNUM WOUND INFECTION; DELIRIUM; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART SURGERY; HUMAN; HYPERGLYCEMIA; INFECTION PREVENTION; INFECTION RISK; INSULIN TREATMENT; LOW DRUG DOSE; MEDIASTINITIS; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; RISK REDUCTION; SINGLE DRUG DOSE; SURGICAL INFECTION; SURGICAL PATIENT; URINARY TRACT INFECTION; VENTILATOR ASSOCIATED PNEUMONIA;

CARDIAC SURGICAL PROCEDURES; EVIDENCE-BASED MEDICINE; HUMANS; PERIOPERATIVE CARE; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES;

EID: 79954415086     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2010.06.002     Document Type: Review

References (120)

1. Anderson RE, Brismar K, Barr G, et al: Effects of cardiopulmonary bypass on glucose homeostasis after coronary artery bypass surgery. Eur J Cardiothorac Surg 28:425-430, 2005 (Pubitemid 41169196)
2. Doenst T, Wijeysundera D, Karkouti K, et al: Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 130:1144-1150, 2005
3. Gandhi GY, Nuttall GA, Abel MD, et al: Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc 80:862-866, 2005 (Pubitemid 40911459)
4. Ouattara A, Lecomte P, Le Manach Y, et al: Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. Anesthesiology 103:687-694, 2005 (Pubitemid 41415516)
5. Furnary AP, Wu Y: Clinical effects of hyperglycemia in the cardiac surgery population: the Portland Diabetic Project. Endocr Pract 12:22-26, 2006 (Pubitemid 44963589)
6. Ingels C, Debaveye Y, Milants I, et al: Strict blood glucose control with insulin during intensive care after cardiac surgery: Impact on 4-year survival, dependency on medical care, and quality-of-life. Eur Heart J 27:2716-2724, 2006 (Pubitemid 44729874)
7. D'Alessandro C, Leprince P, Golmard JL, et al: Strict glycemic control reduces EuroSCORE expected mortality in diabetic patients undergoing myocardial revascularization. J Thorac Cardiovasc Surg 134:29-37, 2007 (Pubitemid 46970705)
8. Ascione R, Rogers CA, Rajakaruna C, et al: Inadequate blood glucose control is associated with in-hospital mortality and morbidity in diabetic and nondiabetic patients undergoing cardiac surgery. Circulation 118:113-123, 2008
9. Donatelli F, Cavagna P, Di Dedda G, et al: Correlation between pre-operative metabolic syndrome and persistent blood glucose elevation during cardiac surgery in non-diabetic patients. Acta Anaesthesiol Scand 52:1103-1110, 2008
10. Jones KW, Cain AS, Mitchell JH, et al: Hyperglycemia predicts mortality after CABG: Postoperative hyperglycemia predicts dramatic increases in mortality after coronary artery bypass graft surgery. J Diabetes Complications 22:365-370, 2008
11. Furnary AP, Gao G, Grunkemeier GL, et al: Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 125:1007-1021, 2003 (Pubitemid 36644877)
12. The Joint Commission: Performance Measurement Initiatives, Current Specification Manual for National Hospital Quality Measures. Available at: http://www.jointcommission.org/PerformanceMeasurement/PerformanceMeasurement/ Current+NHQM+Manual.htmedition. Accessed May 5, 2010
13. Insuring Surgical Care Improvements. Available at: http://medical.wesrch. com/paper-details/pdftext/ME1MS1000IEMO/insuring-surgical-care-improvements. Accessed May 21, 2010
14. Clancy CM: SCIP: Making complications of surgery the exception rather than the rule. AORN J 87:621-624, 2008
15. Van den Berghe G, Wouters P, Weekers F, et al: Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359-1367, 2001
16. Van den Berghe G, Wilmer A, Hermans G, et al: Intensive insulin therapy in the medical ICU. N Engl J Med 354:449-461, 2006 (Pubitemid 43200296)
17. Finfer S, Chittock DR, Su SY, et al: Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283-1297, 2009
18. Griesdale DE, de Souza RJ, van Dam RM, et al: Intensive insulin therapy and mortality among critically ill patients: A metaanalysis including NICE-SUGAR sugar data. CMAJ 180:821-827, 2009
19. Gandhi GY, Nuttall GA, Abel MD, et al: Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: A randomized trial. Ann Intern Med 146:233-243, 2007 (Pubitemid 351650609)
20. Akhtar S, Barash PG, Inzucchi SE: Scientific principles and clinical implications of perioperative glucose regulation and control. Anesth Analg 110:478-497, 2010
21. Fahy BG, Sheehy AM, Coursin DB: Glucose control in the intensive care unit. Crit Care Med 37:1769-1776, 2009
22. Egi M, Bellomo R, Stachowski E, et al: Hypoglycemia and outcome in critically ill patients. Mayo Clin Proc 85:217-224, 2010
23. Meyfroidt G, Keenan DM, Wang X, et al: Dynamic characteristics of blood glucose time series during the course of critical illness: Effects of intensive insulin therapy and relative association with mortality. Crit Care Med 38:1021-1029, 2010
24. Krinsley JS: Glycemic variability: A strong independent predictor of mortality in critically ill patients. Crit Care Med 36:3008-3013, 2008
25. Egi M, Bellomo R, Stachowski E, et al: Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 105:244-252, 2006 (Pubitemid 44148168)
26. Lazar HL, McDonnell M, Chipkin SR, et al: The Society of Thoracic Surgeons practice guideline series: Blood glucose management during adult cardiac surgery. Ann Thorac Surg 87:663-669, 2009
27. Fahy BG, Coursin DB: Critical glucose control: The devil is in the details. Mayo Clin Proc 83:394-397, 2008 (Pubitemid 351536463)
28. Steil GM, Deiss D, Shih J, et al: Intensive care unit insulin delivery algorithms: Why so many? How to choose? J Diabetes Sci Technol 3:125-140, 2009
29. Desachy A, Vuagnat AC, Ghazali AD, et al: Accuracy of bedside glucometry in critically ill patients: Influence of clinical characteristics and perfusion index. Mayo Clin Proc 83:400-405, 2008 (Pubitemid 351536465)
30. Facchinetti A, Sparacino G, Cobelli C: Modeling the error of continuous glucose monitoring sensor data: Critical aspects discussed through simulation studies. J Diabetes Sci Technol 4:4-14, 2010
31. Kohn LT, Corrigan JM, Donaldson MS: To Err is Human: Building a Safer Health System. Washington, D.C., National Academies Press, 2000, pp 7-14
32. Youngquist P, Carroll M, Farber M, et al: Implementing a ventilator bundle in a community hospital. Jt Comm J Qual Patient Saf 33:219-225, 2007
33. Centers for Medicare and Medicaid Services. Available at: http://www.cms.hhs.gov. Accessed May 5, 2010
34. Keib CN, Pelham JC: Mediastinitis following coronary artery bypass graft surgery: Pathogenesis, clinical presentation, risks, and management. J Cardiovasc Nurs 21:493-499, 2006
35. Toumpoulis IK, Theakos N, Dunning J: Does bilateral internal thoracic artery harvest increase the risk of mediastinitis? Interact Cardiovasc Thorac Surg 6:787-791, 2007
36. Dodds Ashley ES, Carroll DN, Engemann JJ, et al: Risk factors for postoperative mediastinitis due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 38:1555-1560, 2004 (Pubitemid 38738550)
37. Mangram AJ, Horan TC, Pearson ML, et al: Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 20:250-278, 1999
38. Edwards FH, Engelman RM, Houck P, et al: The Society of Thoracic Surgeons Practice Guideline Series: Antibiotic Prophylaxis in Cardiac Surgery, Part I: Duration. Ann Thorac Surg 81:397-404, 2006 (Pubitemid 41815461)
39. Eagle KA, Guyton RA, Davidoff R, et al: ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: Summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol 44:e213-e310, 2004
40. Nicholson MR, Huesman LA: Controlling the usage of intranasal mupirocin does impact the rate of Staphylococcus aureus deep sternal wound infections in cardiac surgery patients. Am J Infect Control 34:44-48, 2006 (Pubitemid 43144356)
41. Cimochowski GE, Harostock MD, Brown R, et al: Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics. Ann Thorac Surg 71:1572-1578, 2001
42. Hortal J, Giannella M, Pérez MJ, et al: Incidence and risk factors for ventilator-associated pneumonia after major heart surgery. Intensive Care Med 35:1518-1525, 2009
43. Kollef MH: Prevention of hospital-associated pneumonia and ventilator-associated pneumonia. Crit Care Med 32:1396-1405, 2004
44. Safdar N, Dezfulian C, Collard HR, et al: Clinical and economic consequences of ventilator-associated pneumonia: A systematic review. Crit Care Med 33:2184-2193, 2005
45. Melsen WG, Rovers MM, Bonten MJ: Ventilator-associated pneumonia and mortality: A systematic review of observational studies. Crit Care Med 37:2709-2718, 2009
46. Segers P, de Mol BA: Prevention of ventilator-associated pneumonia after cardiac surgery: Prepare and defend! Intensive Care Med 35:1497-1499, 2009
47. Resar R, Pronovost P, Haraden C, et al: Using a bundle approach to improve ventilator care processes and reduce ventilator-associated pneumonia. Jt Comm J Qual Patient Saf 31:243-248, 2005
48. Dodek P, Keenan S, Cook D, et al: Evidence-based clinical practice guideline for the prevention of ventilator-associated pneumonia. Ann Intern Med 141:305-313, 2004 (Pubitemid 39079293)
49. Griffin FA: Reducing surgical complications. Jt Comm J Qual Patient Saf 33:660-665, 2007
50. Segers P, Speekenbrink R, Ubbink D, et al: Prevention of nosocomial infection in cardiac surgery by decontamination of the nasopharynx and oropharynx with chlorhexidine gluconate: A randomized controlled trial JAMA 296:2460-2466, 2006
51. Koeman M, van der Ven AJ, Hak E, et al: Oral decontamination with chlorhexidine reduces the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med 173:1348-1355, 2006 (Pubitemid 43900709)
52. DeRiso AJ II, Ladowski JS, Dillon TA, et al: Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systematic antibiotic use in patients undergoing heart surgery. Chest 109:1556-1561, 1996 (Pubitemid 26193384)
53. Dezfulian C, Shojania K, Collard HR, et al: Subglottic secretion drainage for preventing ventilator-associated pneumonia: A meta-analysis. Am J Med 118:11-18, 2005 (Pubitemid 40082451)
54. Bouza E, Perez MJ, Munoz P, et al: Continuous aspiration of subglottic secretions in the prevention of ventilator-associated pneumonia in the postoperative period of major heart surgery. Chest 134:938-946, 2008
55. Rello J, Diaz E: Pneumonia in the intensive care unit. Crit Care Med 31:2544-2551, 2003 (Pubitemid 37281742)
56. Bouza E, Burillo A: Advances in the prevention and management of ventilator-associated pneumonia. Curr Opin Infect Dis 22:345-351, 2009
57. Pneumatikos IA, Dragoumanis CK, Bouros DE: Ventilatorassociated pneumonia or endotracheal tube-associated pneumonia? An approach to the pathogenesis and preventive strategies emphasizing the importance of endotracheal tube. Anesthesiology 110:673-680, 2009
58. Institute for Healthcare Improvement: Implement the Ventilator Bundle. Available at: www.ihi.org/IHI/Topics/CriticalCare/IntensiveCare/Changes/ Implementtheventilatorbundle. Accessed May 5, 2010
59. Lucet JC, Bouadma L, Zahar JR, et al: Infectious risk associated with arterial catheters compared with central venous catheters. Crit Care Med 38:1030-1035, 2010
60. Pronovost P, Needham D, Berenholtz S, et al: An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 355:2725-2732, 2006 (Pubitemid 46021509)
61. Venkatram S, Rachmale S, Kanna B: Study of device use adjusted rates in health care-associated infections after implementation of "bundles" in a closed-model medical intensive care unit. J Crit Care 25:174.e11-174.e.18, 2010
62. Hockenhull JC, Dwan KM, Smith GW, et al: The clinical effectiveness of central venous catheters treated with anti-infective agents in preventing catheter-related bloodstream infections: A systematic review. Crit Care Med 37:702-712, 2009
63. Casey AL, Mermel LA, Nightingale P, et al: Antimicrobial central venous catheters in adults: A systematic review and metaanalysis. Lancet Infect Dis 8:763-76, 2008
64. Safdar N, Maki DG: The pathogenesis of catheter-related blood-stream infection with noncuffed short-term central venous catheters. Intensive Care Med 30:62-67, 2004 (Pubitemid 38147108)
65. Weinstein JW, Mazon D, Pantelick E, et al: A decade of prevalence surveys in a tertiary-care center: trends in nosocomial infection rates, device utilization, and patient acuity. Infect Control Hosp Epidemiol 20:543-548, 1999
66. Lo E, Nicolle L, Classen D, et al: Strategies to prevent catheter-associated urinary tract infections in acute care hospitals. Infect Control Hosp Epidemiol 29:S41-S50, 2008
67. Trautner BW: Management of catheter-associated urinary tract infection. Curr Opin Infect Dis 23:76-82, 2010
68. Stephan F, Sax H, Wachsmuth M, et al: Reduction of urinary tract infection and antibiotic use after surgery: A controlled, prospective, before-after intervention study. Clin Infect Dis 42:1544-1551, 2006
69. Johnson JR, Delavari P, Azar M: Activities of a nitrofurazonecontaining urinary catheter and a sliver hydrogel catheter against multidrug-resistant bacteria characteristic of catheter-associated urinary tract infection. Antimicrob Agents Chemother 43:2990-2995, 1999
70. Raz R, Schiller D, Nicolle L: Chronic indwelling catheter replacement before antimicrobial therapy for symptomatic urinary tract infection. J Urol 164:1254-1258, 2000
71. Dunning J, Versteegh M, Fabbri A, et al: Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg 34:73-92, 2008
72. Douketis JD, Berger PB, Dunn AS, et al: The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 133:299S-339S, 2008
73. Katholi RE, Nolan SP, McGuire LB: The management of anticoagulation during noncardiac operations in patients with prosthetic heart valves: a prospective study. Am Heart J 96:163-165, 1978 (Pubitemid 8390630)
74. Douketis JD, Johnson JA, Turpie AG: Low-molecular weight heparin as bridging anticoagulation during interruption of warfarin: Assessment of a standardized periprocedural anticoagulation regimen. Arch Intern Med 164:1319-1326, 2004 (Pubitemid 38828883)
75. Hammerstingl C, Tripp C, Schmidt H, et al: Periprocedural bridging therapy with low-molecular-weight heparin in chronically anticoagulated patients with prosthetic mechanical heart valves: Experience in 116 patients from the prospective BRAVE registry. J Heart Valve Dis 16:285-292, 2007 (Pubitemid 46887057)
76. Spyropoulos AC, Turpie AG, Dunn AS, et al: Perioperative bridging therapy with unfractionated heparin or low-molecular weight heparin in patients with mechanical prosthetic heart valves on longterm oral anticoagulants (from the REGIME Registry). Am J Cardiol 102:883-889, 2008
77. Papadopoulos S, Flynn JD, Lewis DA: Fondaparinux as a treatment option for heparin-induced thrombocytopenia. Pharmacotherapy 27:921-926, 2007 (Pubitemid 46849434)
78. Society of Thoracic Surgeons Blood Conservation Guideline Task Force, Ferraris VA, Ferraris SP, et al: Perioperative blood transfusion and blood conservation in cardiac surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 83:S27-S86, 2007
79. American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiograpahy and Interventions: ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 114:e84-e231, 2006
80. Williams MR, D'Ambra AB, Beck JR, et al: A randomized trial of antithrombin concentrate for treatment of heparin resistance. Ann Thorac Surg 70:873-877, 2000
81. Lemmer JH Jr, Despotis GJ: Antithrombin III concentrate to treat heparin resistance in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 123:213-217, 2002
82. Spiess BD: Treating heparin resistance with antithrombin or fresh frozen plasma. Ann Thorac Surg 85:2153-2160, 2008
83. Mangano DT, Multicenter Study of Perioperative Ischemia Research Group: Aspirin and mortality from coronary bypass surgery. N Engl J Med 347:1309-1317, 2002
84. Yusuf S, Zhao F, Mehta SR, et al: Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345:494-502, 2001 (Pubitemid 32758501)
85. Bhatt DL, Roe MT, Peterson ED, et al: Utilization of early invasive management strategies for high-risk patients with non-STsegment elevation acute coronary syndromes: Results from the CRUSADE Quality Improvement Initiative. JAMA 292:2096-2104, 2004 (Pubitemid 39435100)
86. Grines CL, Bonow RO, Casey DE Jr, et al: Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovaascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol 49:734-739, 2007 (Pubitemid 46210116)
87. Iakovou I, Schmidt T, Bonizzoni E, et al: Incidence, predictors, and outcome of thrombosis after successful implantation of drugeluting stents. JAMA 293:2126-2130, 2005 (Pubitemid 40617065)
88. Jeremias A, Sylvia B, Bridges J, et al: Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation 109:1930-1932, 2004
89. Chou S, Eshaghian S, Lamer A, et al: Bridging therapy in the perioperative management of patients with drug-eluting stents. Rev Cardiovasc Med 10:209-218, 2009
90. Sedrakyan A, Treasure T, Elefteriades JA: Effect of aprotinin on clinical outcomes in coronary artery bypass surgery: A systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg 128:442-448, 2004 (Pubitemid 39194703)
91. Laupacis A, Fergusson D: Drugs to minimize perioperative blood loss in cardiac surgery: Meta-analyses using perioperative blood transfusion as the outcome. Anesth Analg 85:1258-1267, 1997 (Pubitemid 28130521)
92. Fergusson DA, Hebert PC, Mazer CD, et al: A comparison of aprotinin and lysine analogues in high risk cardiac surgery. N Engl J Med. 358:2319-2331, 2008 (Pubitemid 351749156)
93. Kristeller JL, Roslund BP, Stahl RF: Benefits and risks of aprotinin use during cardiac surgery. Pharmacotherapy 28:112-124, 2008
94. American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies: Practice guidelines for perioperative blood transfusion and adjuvant therapies: An updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 105:198-208, 2006
95. Chen A, Teruya J: Global hemostasis testing thromboelastography: Old technology, new applications. Clin Lab Med 29:391-407, 2009
96. Pleym H, Stenseth R, Wahba A, et al: Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesth Analg 98:578-584, 2004 (Pubitemid 38252640)
97. Carless PA, Henry DA, Moxey AJ, et al: Desmopressin use for minimizing perioperative allogeneic blood transfusion (review). Cochrane Database Syst Rev 1:CD001884, 2004
98. Deiner S, Silverstein JH: Postoperative delirium and cognitive dysfunction. Br J Anaesth 103:i41-i46, 2009 (suppl 1)
99. Roach GW, Kanchuger M, Mangano CM, et al: Adverse cerebral outcomes after coronary bypass surgery. Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators. N Engl J Med 335:1857-1863, 1996
100. McKhann GM, Grega MA, Borowicz LM, et al: Stroke and encephalopathy after cardiac surgery: An update. Stroke 37:562-571, 2006 (Pubitemid 43732027)
101. Rasmussen LS: Postoperative cognitive dysfunction: Incidence and prevention. Best Pract Res Clin Anaesthesiol 20:315-330, 2006
102. Rasmussen LS, Larsen K, Houx P, et al: The assessment of postoperative cognitive dysfunction. Acta Anaesthesiol Scand 45:275-289, 2001
103. Funder KS, Steinmetz J, Rasmussen LS: Cognitive dysfunction after cardiovascular surgery. Minevera Anestesiol 75:329-332, 2009
104. Gao L, Taha R, Gauvin D, et al: Postoperative cognitive dysfunction after cardiac surgery. Chest 128:3664-3670, 2005 (Pubitemid 41698708)
105. Slaughter MS, Sobieski MA, Tatooles AJ, et al: Reducing emboli in cardiac surgery: Does it make a difference? Artif Organs 32:880-884, 2008
106. Schmitz C, Weinreich S, White J: Can particulate extraction from the ascending aorta reduce neurologic injury in cardiac surgery? J Thorac Cardiovasc Surg 126:1829-1838, 2003
107. Banbury MK, Kouchoukos NT, Allen KB, et al: Emboli capture using the Embol-X intraaortic filter in cardiac surgery: A multicentered randomized trial of 1289 patients. Ann Thorac Surg 76:508-515, 2003 (Pubitemid 36960599)
108. Wimmer-Greinecker G, International Council of Emboli Management (ICEM) Study Group: Reduction of neurologic complications by intra-aortic filtration in patients undergoing combined intracardiac and CABG procedures. Eur J Cardiothorac Surg 23:159-164, 2003 (Pubitemid 36143775)
109. Takagi H, Tanabashi T, Kawai N, et al: Cognitive decline after off-pump versus on-pump coronary artery bypass graft surgery: Metaanalysis of randomized controlled trials. J Thorac Cardiovasc Surg 134:512-513, 2007
110. Cheng DC, Bainbridge D, Martin JE, et al: Does off-pump coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with conventional coronary artery bypass? A meta-analysis of randomized trials. Anesthesiology 102:188-203, 2005 (Pubitemid 40082856)
111. Marasco SF, Sharwood LN, Abramson MJ: No improvement in neurocognitive outcomes after off-pump versus on-pump coronary revascularization: A meta-analysis. Eur J Cardiothorac Surg 33:961-970, 2008
112. Shroyer AL, Grover FL, Hattler B, et al: On-pump versus off-pump coronary artery bypass surgery. N Engl J Med 361:1827-1837, 2009
113. Sockalingam S, Parekh N, Bogoch II, et al: Delirium in the postoperative cardiac patient: A review. J Card Surg 20:560-567, 2005 (Pubitemid 41726717)
114. Koster S, Hensens AG, van der Palen J: The long-term cognitive and functional outcomes of postoperative delirium after cardiac surgery. Ann Thorac Surg 87:1469-1474, 2009
115. Devlin JW, Fong JJ, Fraser GL, et al: Delirium assessment in the critically ill. Intensive Care Med 33:929-940, 2007 (Pubitemid 46835402)
116. Luetz A, Heymann A, Radtke FM, et al: Different assessment tools for intensive care unit delirium: Which score to use? Crit Care Med 38:409-418, 2010
117. Schwartz TL, Masand PS: The role of atypical antipsychotics in the treatment of delirium. Psychosomatics 43:171-174, 2002 (Pubitemid 34522526)
118. Skrobik YK, Bergeron N, Dumont M, et al: Olanzapine vs. haloperidol: Treating delirium in a critical care setting. Intensive Care Med 30:444-449, 2004 (Pubitemid 38375619)
119. Maldonado JR, Wysong A, van der Starre PJ, et al: Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. Psychosomatics 50:206-217, 2009
120. Riker RR, Shehabi Y, Bokesch PM, et al: Dexmedetomidine vs midazolam for sedation of critically ill patients: A randomized trial. JAMA 301:489-499, 2009